# Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer

> **NCT03940092** · — · UNKNOWN · sponsor: **Cambridge University Hospitals NHS Foundation Trust** · enrollment: 65 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** MRI
- **OTHER:** PET/MRI

## Key facts

- **NCT ID:** NCT03940092
- **Lead sponsor:** Cambridge University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-13
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2022-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03940092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03940092, "Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03940092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*